PATENT CLAIM ANALYSIS

Application Number: 16131003
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["530", "350000"]

Abstract:
The invention herein disclosed is related to epitopes useful in methods of diagnosing, treating, and preventing coeliac disease. Therapeutic compositions which comprise at least one epitope are provided.

Claim (Index 30):
A mutant gluten protein whose wild-type sequence can be modified by a transglutaminase to a sequence which is an agent as defined in  claim 1 , which mutant gluten protein comprises a mutation which prevents its modification by a transglutaminase to a sequence which is an agent as defined in  claim 1 ; or a fragment of such a mutant gluten protein which is at least 7 amino acids long and which comprises the mutation.

Metadata:
- Claim Count in Document: 68.0
- Percentile: 97.0
- Lexical Diversity: 1.06667
- Patent Class: 530.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14630004', '13541864', '10516837', '10089700', '11630818']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7032347896378913
- 35 USC 102 Novelty (BERT): 0.567651918769075
- Combined Prediction Score: 0.6896765025510098
- Mean Citation Score: 413.16597999999993
- Max Citation Score: 487.38614
- Similarity Product: 326.63177725000145

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test